Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ABBVIE INC.

(ABBV)
  Rapport
Vertraagde tijd Nyse  -  22:04 29-09-2022
142.72 USD   -1.30%
27/09AbbVie Inc. Kondigt XEN® 63 Gel Implantaat aan, nu beschikbaar voor patiënten met Primair Open Hoek Glaucoom waar eerdere medische behandelingen hebben gefaald.
CI
22/09Amerikaanse aandelen eindigen donderdag lager ondanks stijgingen in de gezondheidszorg
MT
22/09Amerikaanse aandelen eindigen donderdag lager ondanks stijging aandelen gezondheidszorg
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiële publicatiesSectornieuws
Nieuws in andere talen op ABBVIE INC.
29/09AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease an..
27/09XEN® 63 Gel Implant available now for patients with primary open angle glaucoma where p..
27/09AbbVie Inc. Announces XEN® 63 Gel Implant Available Now for Patients with Primary Open ..
23/09AbbVie - The Forces of Beauty Report from the DREAM Initiative Reveals Demand for New S..
23/09Ça va pas très fort
23/09EN DIRECT DES MARCHES : Schneider, L'Oréal, Faurecia, TF1, Casino,..
22/09US Stocks End Lower Thursday Despite Healthcare Gains
22/09US Stocks End Lower Thursday Despite Surge in Healthcare Shares
20/09AbbVie Secures Positive CHMP Opinion for Risankizumab for the Treatment of Adults with ..
19/09AbbVie Says CMHP Recommends European Approval of Risankizumab for Treatment of Crohn's ..
19/09AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of A..
19/09Abbvie Inc. Secures Positive Chmp Opinion for Risankizumab (Skyrizi®) for the Treatment..
16/09Bristol Myers, AbbVie plan to cut up to 360 California jobs
16/09USA-Les valeurs à suivre à Wall Street (actualisé)
16/09Consumer group says drugmakers abuse U.S. patent system to keep prices high
15/09AbbVie to Present Data from Growing Neuroscience and Movement Disorders Portfolio at 20..
14/09Allergan Aesthetics and BOTOX Cosmetic Reveal New 'See Yourself' Campaign Cast, Spotlig..
13/09Transcript : AbbVie Inc. Presents at Morgan Stanley 20th Annual Global Health..
13/09Allergan Aesthetics and BOTOX® Cosmetic (OnabotulinumtoxinA) Reveal New 'See Yourself' ..
12/09Abbvie - New Late-Breaking Results from Phase 3 Trials of SKYRIZI Evaluating Long-term ..
12/09AbbVie Declares Quarterly Dividend
10/09Abbvie Announces Results from Phase 3 Trials of SKYRIZI® (risankizumab)
09/09AbbVie Maintains Quarterly Dividend at $1.41 a Share, Payable Nov. 15 to Holders of Rec..
09/09AbbVie Declares Quarterly Dividend
09/09AbbVie Inc. Declares Quarterly Cash Dividend, Payable on November 15, 2022
09/09AbbVie - New MEASURE-AD Analyses Evaluate Clinical, Psychosocial and Economic Burdens i..
08/09Allergan Aesthetics Celebrates 100 Million Syringes of JUVEDERM
08/09New MEASURE-AD Analyses Evaluate Clinical, Psychosocial and Economic Burdens in Atopic ..
08/09AbbVie Inc. Announces New MEASURE-AD Analyses Evaluate Clinical, Psychosocial and Econo..
08/09AbbVie to Present Data From its Robust Migraine Portfolio at the Migraine Trust Interna..
07/09Allergan Aesthetics Celebrates 100 Million Syringes of JUVÉDERM®
07/09AbbVie to Present at the Morgan Stanley Healthcare Conference
06/09Ironwood Pharmaceuticals Says Linzess Meets Primary, Secondary Endpoints in Phase 3 Tri..
01/09AbbVie - SkinMedica Launches Firm and Tone Lotion for Body
01/09Le blues de la rentrée ?
01/09Avis d'analystes du jour : LVMH, Société Générale, Legrand, Als..
31/08SkinMedica® Launches Firm & Tone Lotion for Body
31/08Tentative de reconnexion
31/08EN DIRECT DES MARCHES : Engie, TotalEnergies, Renault, BioMérieux,..
30/08AbbVie Showcases New Analyses and Real-World Data across Multiple Immune-Mediated Skin ..
29/08AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin ..
29/08AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin ..
25/08Abbvie - Children with Chronic Graft Versus Host Disease (cGVHD) May Now Be Prescribed ..
25/08AbbVie, Janssen's Imbruvica Gets US FDA Approval for Use as Treatment of Pediatric Pati..
25/08Children with Chronic Graft Versus Host Disease (cGVHD) May Now Be Prescribed IMBRUVICA..
25/08AbbVie Announces the U.S. Food and Drug Administration Approves the Use of IMBRUVICA fo..
22/08Hiring and data: how the U.S. will set up new Medicare drug price talks
18/08Allergan Aesthetics - Experience the JUVEDERM Difference with Allergan Aesthetics
18/08AbbVie Gets UK National Health Institue's Recommendation For Ankylosing Spondylitis The..
17/08Pharmacies ordered to pay $650.6 million to Ohio counties in opioid case
17/08I-Mab Partner AbbVie Discontinues Early-Stage Study of Cancer Treatment; Companies Amen..
17/08Experience the JUVÉDERM® Difference with Allergan Aesthetics
12/08AbbVie's Eye Disease Drug Recommended For Extended Use In British Healthcare System
11/08The Seventh Circuit Asks, "What's Wrong With Having Lots Of Patents?"
11/08Senate Finance Committee looks at Amgen taxes, widening drugmaker probe
11/08Global markets live: Walt Disney, Bank of America, Sonos, ABB, Roche..
11/08C'est toujours ça de prix
11/08EN DIRECT DES MARCHES : Vinci, Casino, Valneva, Siemens, Disney, Z..
09/08Few U.S. patients with hepatitis C get timely treatment, CDC says
09/08Arecor Granted EU Patent Protection for High-Concentration Version of AbbVie's Adalimum..
05/08Focus: 5 Stocks for Yield Lovers
04/08ABBVIE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
04/08Tranche Update on AbbVie Inc.'s Equity Buyback Plan announced on February 15, 2018.
04/08AbbVie's Humira Patent Settlement Not A Violation Of Sherman Antitrust Act, Seventh Cir..
04/08Global markets live: Bayer, Merck, eBay, MetLife, Eli Lilly...
04/08FDA Approves JUVEDERM VOLUX XC for Improvement of Jawline Definition
04/08La "Tech" en a marre de baisser
04/08EN DIRECT DES MARCHES : Crédit Agricole, SES, Equasens, Adecco, Ad..
03/08AbbVie's Allergan Aesthetics Gets FDA Approval for Gel to Improve Jawline Definition
03/08FDA Approves JUVÉDERM® VOLUX™ XC for Improvement of Jawline Definition
02/08Où l'on reparle de Taiwan
02/08Avis d'analystes du jour : TotalEnergies, Nestlé, Novartis, ADP..
02/08Sosei Heptares and AbbVie Enter New Multi-Target Collaboration to Discover, Develop and..
01/08AbbVie's Neutral Rating Maintained at Goldman Even as Skyrizi Sales Jump
01/08AbbVie - RINVOQ (upadacitinib) Approved by European Commission as an Oral Treatment for..
01/08AbbVie Reports Second-Quarter 2022 Financial Results
29/07Health Care Down After Mixed Earnings -- Health Care Roundup
29/07AbbVie Posts Higher Second-Quarter Results, Revenue Misses Analyst Estimates
29/07AbbVie Down Over 6%, on Pace for Largest Percent Decrease Since September 2021 -- Data ..
29/07AbbVie's Allergan in Pact for Opioid Settlement, NC AG Says
29/07AbbVie Guides Q3 Revenue to $14.3 Bln vs $15.3 Bln Estimates
29/07Transcript : AbbVie Inc., Q2 2022 Earnings Call, Jul 29, 2022
29/07Aktien New York Ausblick: Starke Wochenbilanz - Apple und Amazo..
29/07AbbVie : 14,583 milliards de dollars de recette nette
29/07Abbvie : Reports Second-Quarter 2022 Financial Results - Form 8-K
29/07AbbVie's Q2 Adjusted Earnings, Revenue Increase
29/07Abbvie : Q2 Earnings Snapshot
29/07AbbVie sets aside $2 billion to settle U.S. opioid claims
29/07Earnings Flash (ABBV) ABBVIE Reports Q2 Revenue $14.58B
29/07Earnings Flash (ABBV) ABBVIE Posts Q2 EPS $3.37
29/07AbbVie Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 3..
29/07Wall Street Leans Forward Pre-Bell; Futures Green, Europe Up, Asia Mixed
29/07North American Morning Briefing: Apple, Amazon -2-
29/07AbbVie Gets Marketing Approval in Europe for Axial Spondyloarthritis Drug
29/07Mauvaise nouvelle ? Bonne nouvelle !
29/07EN DIRECT DES MARCHES : BNP Paribas, Hermès, Engie, Renault, L'Oré..
29/07RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults ..
29/07European Commission Approves Abbvie's Rinvoq® (Upadacitinib) as an Oral Treatment for A..
29/07Reuters-schedule/…
28/07AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ) in Croh..
Volgende evenement op ABBVIE INC.